Cancer drugs

Recent Articles

RELATED ARTICLES

  1. The drug maker boosted sales of its core anti-cancer product in the first half of the year and reined in its research budget under a reform-minded CEO, but revenue momentum lags the pace of leading rivals.
    Junshi narrows its losses but delivers no cure for share price woes
    1877.HK 688180.SHG
  2. Junshi hopes new scientist CEO can cure its woes
    1877.HK 688180.SHG
  3. Akeso marks profit milestone with swift rights issue
    9926.HK
  4. HBM gets health boost from drug licensing deals
    2142.HK
  5. CSPC Pharma weighs up diet drug for bigger bottom line
    1093.HK
  6. Test results for new cancer drug take Akeso investors on wild ride
    9926.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva